KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Want to see JP:4569 full AI Analyst Report?
Total Valuation
KYORIN Pharmaceutical Co.,Ltd. has a market cap or net worth of ¥68.12B. The enterprise value is ¥89.77B.
Market Cap¥68.12B
Enterprise Value¥89.77B
Share Statistics
KYORIN Pharmaceutical Co.,Ltd. has 59,945,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,945,640
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
KYORIN Pharmaceutical Co.,Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.63%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)1.63%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee61.83M
Profits Per Employee1.69M
Employee Count2,042
Asset Turnover0.65
Inventory Turnover1.10
Valuation Ratios
The current PE Ratio of KYORIN Pharmaceutical Co.,Ltd. is 27.4. KYORIN Pharmaceutical Co.,Ltd.’s PEG ratio is -0.44.
PE Ratio27.4
PS Ratio0.75
PB Ratio0.66
Price to Fair Value0.66
Price to FCF37.55
Price to Operating Cash Flow0.00
PEG Ratio-0.44
Income Statement
In the last 12 months, KYORIN Pharmaceutical Co.,Ltd. had revenue of 126.26B and earned 3.45B in profits. Earnings per share was 60.02.
Revenue126.26B
Gross Profit51.61B
Operating Income3.57B
Pretax Income4.45B
Net Income3.45B
EBITDA8.22B
Earnings Per Share (EPS)60.02
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
KYORIN Pharmaceutical Co.,Ltd. pays an annual dividend of ¥37, resulting in a dividend yield of 3.36%
Dividend Per Share¥37
Dividend Yield3.36%
Payout Ratio32.04%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change-8.93%
50-Day Moving Average1.57K
200-Day Moving Average1.52K
Relative Strength Index (RSI)19.97
Average Volume (3m)127.03K
Important Dates
KYORIN Pharmaceutical Co.,Ltd. upcoming earnings date is Jul 30, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
KYORIN Pharmaceutical Co.,Ltd. as a current ratio of 4.60, with Debt / Equity ratio of 16.70%
Current Ratio4.60
Quick Ratio2.29
Debt to Market Cap0.25
Net Debt to EBITDA1.46
Interest Coverage Ratio14.04
Taxes
In the past 12 months, KYORIN Pharmaceutical Co.,Ltd. has paid 1.00B in taxes.
Income Tax1.00B
Effective Tax Rate0.23
Enterprise Valuation
KYORIN Pharmaceutical Co.,Ltd. EV to EBITDA ratio is 12.95, with an EV/FCF ratio of 42.31.
EV to Sales0.84
EV to EBITDA12.95
EV to Free Cash Flow42.31
EV to Operating Cash Flow16.69
Balance Sheet
KYORIN Pharmaceutical Co.,Ltd. has ¥16.62B in cash and marketable securities with ¥26.48B in debt, giving a net cash position of -¥9.87B billion.
Cash & Marketable Securities¥16.62B
Total Debt¥26.48B
Net Cash-¥9.87B
Net Cash Per Share-¥164.62
Tangible Book Value Per Share¥2.48K
Margins
Gross margin is 40.88%, with operating margin of 2.83%, and net profit margin of 2.73%.
Gross Margin40.88%
Operating Margin2.83%
Pretax Margin3.53%
Net Profit Margin2.73%
EBITDA Margin6.51%
EBIT Margin2.83%
Analyst Forecast
The average price target for KYORIN Pharmaceutical Co.,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.94%
EPS Growth Forecast-62.05%